|By Marketwired .||
|April 29, 2014 07:00 PM EDT||
SAN DIEGO, CA -- (Marketwired) -- 04/29/14 -- Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cell-based virology assays and molecular diagnostic systems, announced today that it will present at the Bank of America Merrill Lynch 2014 Health Care Conference to be held at the Encore at Wynn hotel in Las Vegas, Nevada on Tuesday, May 13, 2014.
Douglas Bryant, president and chief executive officer, and Randy Steward, chief financial officer, will present that day at 6:00 p.m. Eastern time (3:00 p.m. Pacific time) with a question and answer session scheduled immediately following the presentation. During the presentation, the company will discuss business and financial developments and trends. The company's statements may contain or constitute material information that has not been previously disclosed.
A live webcast and audio archive of the presentation will be available via the Investor Relations section of the company's Web site at www.quidel.com. Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast. A replay of the webcast will also be available on the company's Web site for 14 days.
About Quidel Corporation
Quidel Corporation serves to enhance the health and wellbeing of people around the globe through the development of diagnostic solutions that can lead to improved patient outcomes and provide economic benefits to the healthcare system. Marketed under the QuickVue®, D3® Direct Detection and Thyretain® leading brand names, as well as under the new Sofia®, AmpliVue® and Lyra brands, Quidel's products aid in the detection and diagnosis of many critical diseases and conditions, including, among others, influenza, respiratory syncytial virus, Strep A, herpes, pregnancy, thyroid disease and fecal occult blood. Quidel's research and development engine is also developing a continuum of diagnostic solutions from advanced lateral-flow and direct fluorescent antibody to molecular diagnostic tests to further improve the quality of healthcare in physicians' offices and hospital and reference laboratories. For more information about Quidel's comprehensive product portfolio, visit quidel.com.
Chief Financial Officer
Media and Investors Contact:
Traditional on-premises data centers have long been the domain of modern data platforms like Apache Hadoop, meaning companies who build their business on public cloud were challenged to run Big Data processing and analytics at scale. But recent advancements in Hadoop performance, security, and most importantly cloud-native integrations, are giving organizations the ability to truly gain value from all their data. In his session at 19th Cloud Expo, David Tishgart, Director of Product Marketing ...
Aug. 30, 2016 05:00 PM EDT Reads: 889
Aug. 30, 2016 04:15 PM EDT Reads: 954
Aug. 30, 2016 03:30 PM EDT Reads: 3,766
Aug. 30, 2016 03:00 PM EDT Reads: 846
Aug. 30, 2016 02:30 PM EDT Reads: 948
Aug. 30, 2016 02:30 PM EDT Reads: 1,033
Aug. 30, 2016 02:00 PM EDT Reads: 3,760
Aug. 30, 2016 01:45 PM EDT Reads: 647
Aug. 30, 2016 01:30 PM EDT Reads: 866
Aug. 30, 2016 01:20 PM EDT Reads: 249
Aug. 30, 2016 01:15 PM EDT Reads: 2,065
Aug. 30, 2016 01:00 PM EDT Reads: 3,230
Aug. 30, 2016 11:45 AM EDT Reads: 799
Aug. 30, 2016 10:30 AM EDT Reads: 413
As the world moves toward more DevOps and Microservices, application deployment to the cloud ought to become a lot simpler. The Microservices architecture, which is the basis of many new age distributed systems such as OpenStack, NetFlix and so on, is at the heart of Cloud Foundry - a complete developer-oriented Platform as a Service (PaaS) that is IaaS agnostic and supports vCloud, OpenStack and AWS. Serverless computing is revolutionizing computing. In his session at 19th Cloud Expo, Raghav...
Aug. 30, 2016 09:45 AM EDT Reads: 1,073